Malignant Ascites: Clinical Trials

2 trials for Malignant Ascites, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow Malignant Ascites: new trials by email Literature Review of Malignant Ascites trials Research Report on Malignant Ascites

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Ascites
SCB-313 - Malignant Ascites
Phase 1CompletedSichuan Clover Biopharmaceuticals, Inc.132019-09-282022-05-06
A Study of M701 (EpCAM and CD3) in Malignant Ascites
Cohort 1 of M701, Cohort 2 of M701, Cohort 3 of M701 - Malignant Ascites, Cancer
Phase 1CompletedWuhan YZY Biopharma Co., Ltd.352018-09-302025-07-17

Narrower conditions

Neoplasms (1)

Sponsors

Sichuan Clover Biopharmaceuticals, Inc. (1)  ·  Wuhan YZY Biopharma Co., Ltd. (1)

Countries

China (2)

Top investigators

Jianming Xu (1)  ·  Shixuan Wang (1)